1 study found for:
NCT00220415
| Rank | Status | Study | ||||
|---|---|---|---|---|---|---|
| 1 | Completed |
A Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel Group Trial to Investigate the Efficacy and Safety of SPM 927 (200mg/Day and 400mg/Day) as Adjunctive Therapy in Subjects With Partial Seizures With or Without Secondary Generalization
|
† Indicates status has not been verified in more than two years